Dr. Katzenellenbogen named co-leader of IU Simon Comprehensive Cancer Center research program
Rachel Katzenellenbogen, M.D., has been named a co-leader of the Cancer Prevention and Control research program at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center.
Rachel Katzenellenbogen, M.D., has been named a co-leader of the Cancer Prevention and Control research program at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center. She serves along with Susan Rawl, Ph.D., and Todd Skaar, Ph.D.
A member of the program since 2018, Katzenellenbogen is the chief of the Division of Adolescent Medicine in the Department of Pediatrics, associate professor of pediatrics and of microbiology and immunology, and the Richard E. and Pauline P. Klingler Scholar in Pediatrics at IU School of Medicine. She is also the Chuck and Tina Pagano Scholar at the cancer center.
Katzenellenbogen’s cancer research focuses on the fundamental way human papillomavirus drives cancer development and progression, how that drive is common to all cancers or is unique to this infection-associated cancer, and identifying ways to detect and disrupt these pathways to intervene early in treatment.
Before joining IU, Katzenellenbogen was an associate professor of pediatrics at the University of Washington and Seattle Children’s Research Institute. She graduated magna cum laude from Harvard University and earned her medical degree from the Johns Hopkins University School of Medicine. She completed her residency in the Department of Pediatrics and fellowships in the Division of Adolescent Medicine and the Center for AIDS and STD Research at the University of Washington.
She is a member of the American Association for Cancer Research, the American Academy of Pediatrics, and the Society for Adolescent Health and Medicine.
The goal of the Cancer Prevention and Control research program is to reduce the incidence, morbidity, and mortality of cancer for the citizens of Indiana and beyond.
/* Style Definitions */
mso-padding-alt:0in 5.4pt 0in 5.4pt;
font-family:”Times New Roman”,serif;}